SI2485751T1 - Glyx-13 za uporabo pri postopku za zdravljenje refraktorne depresije - Google Patents
Glyx-13 za uporabo pri postopku za zdravljenje refraktorne depresijeInfo
- Publication number
- SI2485751T1 SI2485751T1 SI201030702T SI201030702T SI2485751T1 SI 2485751 T1 SI2485751 T1 SI 2485751T1 SI 201030702 T SI201030702 T SI 201030702T SI 201030702 T SI201030702 T SI 201030702T SI 2485751 T1 SI2485751 T1 SI 2485751T1
- Authority
- SI
- Slovenia
- Prior art keywords
- glyx
- refractory depression
- treating refractory
- treating
- depression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Ceramic Products (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24865009P | 2009-10-05 | 2009-10-05 | |
| PCT/US2010/051415 WO2011044089A2 (en) | 2009-10-05 | 2010-10-05 | Methods of treating depression and other related diseases |
| EP10822514.5A EP2485751B1 (en) | 2009-10-05 | 2010-10-05 | GLYX-13 for use in a method of treating refractory depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2485751T1 true SI2485751T1 (sl) | 2014-10-30 |
Family
ID=43857351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201030702T SI2485751T1 (sl) | 2009-10-05 | 2010-10-05 | Glyx-13 za uporabo pri postopku za zdravljenje refraktorne depresije |
Country Status (12)
| Country | Link |
|---|---|
| EP (4) | EP2485751B1 (sl) |
| CY (1) | CY1118530T1 (sl) |
| DK (2) | DK2985032T3 (sl) |
| ES (2) | ES2493316T3 (sl) |
| HR (1) | HRP20140784T1 (sl) |
| HU (1) | HUE043807T2 (sl) |
| PL (2) | PL2485751T3 (sl) |
| PT (2) | PT2485751E (sl) |
| RS (1) | RS53513B1 (sl) |
| SI (1) | SI2485751T1 (sl) |
| SM (1) | SMT201400117B (sl) |
| WO (1) | WO2011044089A2 (sl) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010033757A1 (en) | 2008-09-18 | 2010-03-25 | Naurex, Inc. | Nmda receptor modulators and uses thereof |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| KR101692275B1 (ko) * | 2010-02-11 | 2017-01-04 | 노오쓰웨스턴 유니버시티 | ２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도 |
| SG10201501050RA (en) | 2010-02-11 | 2015-04-29 | Univ Northwestern | Secondary Structure Stabilized NMDA Receptor Modulators And Uses Thereof |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| US10583138B2 (en) | 2012-07-12 | 2020-03-10 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| MX357761B (es) * | 2011-04-27 | 2018-07-23 | Univ Northwestern | Métodos para tratar la enfermedad de alzheimer, enfermedad de huntington, autismo u otros trastornos. |
| US20150253305A1 (en) * | 2012-10-12 | 2015-09-10 | Northwestern University | Methods of identifying compounds for treating depression and other related diseases |
| BR112015018094A2 (pt) | 2013-01-29 | 2017-07-18 | Naurex Inc | moduladores de receptor nmda de espiro-lactama e usos dos mesmos |
| EA201591404A1 (ru) | 2013-01-29 | 2016-01-29 | Аптиникс Инк. | Спиролактамные модуляторы рецептора nmda и их применение |
| JP2016506958A (ja) | 2013-01-29 | 2016-03-07 | ノーレックス, インコーポレイテッドNaurex, Inc. | スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用 |
| BR112015018092A2 (pt) | 2013-01-29 | 2017-07-18 | Naurex Inc | moduladores de receptor de nmda de espiro-lactama e usos dos mesmos |
| JP6531042B2 (ja) | 2013-01-29 | 2019-06-12 | アプティニックス インコーポレイテッド | スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用 |
| CA2933372A1 (en) * | 2013-12-13 | 2015-06-18 | Northwestern University | Methods of treating brain disorders or identifying biomarkers related thereto |
| CN105327349A (zh) * | 2014-06-18 | 2016-02-17 | 上海翰森生物医药科技有限公司 | Nmda受体拮抗剂的医药用途及其药物组合物 |
| RU2721401C2 (ru) * | 2014-06-23 | 2020-05-19 | Нортвестерн Юниверсити | Способы лечения или облегчения мигрени |
| UA123623C2 (uk) * | 2014-08-14 | 2021-05-05 | Наурекс, Інк. | Способи лікування депресії із застосуванням модуляторів nmda |
| EP3362080A1 (en) * | 2015-10-16 | 2018-08-22 | Northwestern University | Pharmaceutical combination of an atypical antipsychotic and an nmda modulator for the treatment of schizophrenia,bipolar disorder, cognitive impairment and major depressive disorder |
| WO2017189920A1 (en) * | 2016-04-28 | 2017-11-02 | The Trustees Of The University Of Pennsylvania | Method of drug design and optimisation utilizing stereochemical mimicry |
| WO2017201285A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| KR102128675B1 (ko) | 2016-05-19 | 2020-06-30 | 앱티닉스 인크. | 스피로-락탐 nmda 수용체 조정제 및 그의 용도 |
| JP2019527233A (ja) | 2016-08-01 | 2019-09-26 | アプティニックス インコーポレイテッド | スピロ−ラクタムｎｍｄａ受容体修飾因子及びその使用 |
| KR102503590B1 (ko) | 2016-08-01 | 2023-02-24 | 앱티닉스 인크. | 스피로-락탐 nmda 수용체 조정제 및 그의 용도 |
| US11028095B2 (en) | 2016-08-01 | 2021-06-08 | Aptinyx Inc. | Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof |
| EA201990428A1 (ru) | 2016-08-01 | 2019-08-30 | Аптиникс Инк. | Спиролактамовые модуляторы nmda-рецептора и их применение |
| PE20190501A1 (es) | 2016-08-01 | 2019-04-10 | Aptinyx Inc | Moduladores nmda espiro-lactam y metodos de uso de los mismos |
| KR20200115611A (ko) | 2018-01-31 | 2020-10-07 | 앱티닉스 인크. | 스피로-락탐 nmda 수용체 조정제 및 그의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4086196A (en) | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
| US5763393A (en) * | 1996-05-17 | 1998-06-09 | Neurotherapeutics L.P. | Neuroactive peptides |
| US20030065138A1 (en) * | 2001-03-07 | 2003-04-03 | University Of Utah Research Foundation | Linear gamma-carboxyglutamate rich conotoxins |
| AU2002255705A1 (en) * | 2001-03-12 | 2002-09-24 | Nyxis Neurotherapies, Inc | Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain |
| WO2005014797A2 (en) * | 2003-08-08 | 2005-02-17 | The Burnham Institute | P16 mediated regulation of nmda receptors |
| US20050096311A1 (en) * | 2003-10-30 | 2005-05-05 | Cns Response | Compositions and methods for treatment of nervous system disorders |
-
2010
- 2010-10-05 PT PT108225145T patent/PT2485751E/pt unknown
- 2010-10-05 EP EP10822514.5A patent/EP2485751B1/en active Active
- 2010-10-05 EP EP18248179.6A patent/EP3488856A1/en not_active Ceased
- 2010-10-05 SI SI201030702T patent/SI2485751T1/sl unknown
- 2010-10-05 ES ES10822514.5T patent/ES2493316T3/es active Active
- 2010-10-05 PT PT15171991T patent/PT2985032T/pt unknown
- 2010-10-05 ES ES15171991T patent/ES2721448T3/es active Active
- 2010-10-05 DK DK15171991.1T patent/DK2985032T3/en active
- 2010-10-05 RS RSP20140441 patent/RS53513B1/en unknown
- 2010-10-05 EP EP15171991.1A patent/EP2985032B1/en active Active
- 2010-10-05 DK DK10822514.5T patent/DK2485751T3/da active
- 2010-10-05 PL PL10822514T patent/PL2485751T3/pl unknown
- 2010-10-05 WO PCT/US2010/051415 patent/WO2011044089A2/en active Application Filing
- 2010-10-05 PL PL15171991T patent/PL2985032T3/pl unknown
- 2010-10-05 EP EP14169137.8A patent/EP2813236A1/en not_active Withdrawn
- 2010-10-05 HU HUE15171991A patent/HUE043807T2/hu unknown
-
2014
- 2014-08-13 CY CY20141100649T patent/CY1118530T1/el unknown
- 2014-08-19 HR HRP20140784AT patent/HRP20140784T1/hr unknown
- 2014-08-19 SM SM201400117T patent/SMT201400117B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2985032T3 (en) | 2019-04-15 |
| EP2985032A1 (en) | 2016-02-17 |
| PT2485751E (pt) | 2014-09-01 |
| ES2721448T3 (es) | 2019-07-31 |
| HUE043807T2 (hu) | 2019-09-30 |
| EP2485751A2 (en) | 2012-08-15 |
| ES2493316T3 (es) | 2014-09-11 |
| PL2985032T3 (pl) | 2019-07-31 |
| CY1118530T1 (el) | 2017-07-12 |
| EP2985032B1 (en) | 2019-01-02 |
| DK2485751T3 (da) | 2014-08-18 |
| HRP20140784T1 (hr) | 2014-10-10 |
| RS53513B1 (en) | 2015-02-27 |
| EP2485751B1 (en) | 2014-05-21 |
| PT2985032T (pt) | 2019-04-24 |
| EP2813236A1 (en) | 2014-12-17 |
| EP2485751A4 (en) | 2013-03-13 |
| WO2011044089A3 (en) | 2012-02-16 |
| WO2011044089A2 (en) | 2011-04-14 |
| EP3488856A1 (en) | 2019-05-29 |
| PL2485751T3 (pl) | 2014-10-31 |
| SMT201400117B (it) | 2014-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2485751E (pt) | Glyx-13 para uso num método para tratar depressão refratária | |
| HK1255283A1 (zh) | 用於治療流感的化合物和方法 | |
| EP2350793A4 (en) | ARRANGEMENT FOR A TOUCH SCREEN AND METHOD FOR MANUFACTURING THE SAME | |
| EP2424352A4 (en) | METHODS AND COMPOSITION FOR TREATING MATERIAL | |
| EP2375903A4 (en) | METHOD FOR TREATING SILENTNESS | |
| GB0900891D0 (en) | A unit for and method of treating waste | |
| IL214919A0 (en) | Method for therapeutic use | |
| GB0902705D0 (en) | Surface treatment process for implant | |
| GB0908506D0 (en) | Method and apparatus for drawing polygons | |
| IL217492A0 (en) | Treatment method | |
| EP2453896A4 (en) | PROCESS FOR TREATING SCHIZOPHRENIA | |
| EP2482567A4 (en) | METHOD AND APPARATUS FOR STATUS TRANSITION | |
| GB2483792B (en) | Waste treatment method | |
| HK1167167A1 (en) | Heater-dryer and control method for heater-dryer | |
| PL2440642T3 (pl) | Sposób zmniejszania złych zapachów | |
| EP2260237A4 (en) | METHOD FOR OPERATING A HIGH FOOD | |
| GB2471907B (en) | A method of treating diamond | |
| PL2439289T3 (pl) | Sposób i piec do obróbki cieplnej przedmiotów obrabianych | |
| HK1134746A2 (en) | Method for treating boiler surface | |
| PL2336380T3 (pl) | Sposób i narzędzie do obróbki powierzchni | |
| EP2424539A4 (en) | PROCESS FOR TREATING DEPRESSION | |
| GB0907249D0 (en) | New process and new compounds | |
| IL217326A0 (en) | Method and device for treating substrates | |
| GB0820165D0 (en) | Process for treatment of materials in a vessel | |
| GB2483039B (en) | Method for treating hydrocarbons |